Investors have been left with mixed emotions regarding the stock price performance over the year, as it’s been a mixed bag. The metric has seen a significant loss of -37.65% since the start of this calendar year. Looking back over the last six months, we can see a weaker performance of 23.60%. Over the past 30 days, the price of NMRA has fallen by 9.14%. And in the last five days, it has fallen by -2.16%.
The stock market performance of Neumora Therapeutics Inc has been fairly unsteady. Over the last year, the company’s stock hit its highest at $21.00 on 03/08/24, while the lowest price during the same time frame was $8.33, recorded on 06/26/24.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
52-week price history of NMRA Stock
A stock’s 52-week price history, including the low and high prices, can offer valuable insights into its current standing and future prospects. Neumora Therapeutics Inc’s current trading price is -49.38% away from its 52-week high, while its distance from the 52-week low is 27.61%. The stock’s price range over this timeframe has been between $8.33 and $21.00. The shares of the Healthcare sector company recorded a trading volume of approximately 0.52 million for the day, which was comparatively lower than the average daily volume of 1.09 million over the last three months.
The Connection Between Financial Performance and Market Capitalization
Neumora Therapeutics Inc (NMRA) has experienced a quarterly decline of -16.95% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 1.64B and boasts a workforce of 124 employees.
How Moving Averages and Trading Volume Data Work Together
Based on Barchart.com data, the company’s moving average over the 100-day period was 11.94, with a change in price of -1.88. Similarly, Neumora Therapeutics Inc recorded 932,293 in trading volume during the last 100 days, posting a change of -15.03%.
NMRA’s Debt-to-Equity Ratio: A Comprehensive Review
A key metric for assessing a company’s financial well-being and market status is the debt-to-equity (D/E) ratio. This ratio is derived by dividing a company’s total liabilities by its shareholders’ equity, and it demonstrates the level of debt a company uses to support its assets relative to shareholder equity. At the time of writing, the total D/E ratio for NMRA stands at 0.01. Similarly, the long-term debt-to-equity ratio is also 0.00.
NMRA Stock Stochastic Average
The raw stochastic average for Neumora Therapeutics Inc over the last 50 days is presently at 16.44%. This reflects a drop from the raw stochastic average of the previous 20 days, which was noted at 62.91%. Further, the company’s Stochastic %K and %D values for the last 20 days were 77.67% and 72.99%, respectively.
